Tag Archives: chemotherapy
Ipilimumab – new option for Metastatic Melanoma patients
At ASCO this past weekend, Dr. Steven O’Day reported that ipilimumab alone or in combination with vaccine increased overall survival (OS) in patients with unresectable stage III/IV melanoma for whom previous treatment had failed (Abstract 4). Metastatic (stage IV) melanoma is very … Continue reading
Standard Chemo Better Than Oral Capecitabine in Elderly Breast Cancer
Most elderly breast cancer patients would prefer oral chemotherapy such as capecitabine (Xeloda, Roche) over intravenous chemotherapy due to the convenience. However, a clinical trial conducted in elderly women with early-stage breast cancer has found that standard adjuvant combination chemotherapy … Continue reading
New treatment modality (Yttrium-90 Microspheres) Improves Survival in Patients With Liver Cancer
Each year, there are about 18,500 cases of primary liver cancer diagnosed and the most common form is hepatocellular carcinoma. However, more than 75% of hepatocellular carcinoma patients can not have surgery to remove their liver tumors and chemotherapy and … Continue reading
Best Regimen Sequence for Early Breast Cancer patients
Which is the best chemotherapy adjuvant regimen sequence for early breast cancer? It is widely known that anthracyclines (epirubicin and doxorubicin) and taxanes is the best adjuvant chemotherapy regimen for early breast cancer. However, should anthracyclines be always administered before taxanes? An article published … Continue reading
Alternative Treatment Options for Late Stage Lung Cancer Patients
Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients. However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading
New Drug Offer Hope to Patients with Late Stage Prostate Cancer
At present, metastatic and hormonal-refractory prostate cancer patients who have failed 1st line chemotherapy will be given mitoxantrone plus prednisone as the salvage therapy. However, mitoxantrone plus prednisone is not very effective in controlling metastatic prostate cancer. Now, a new … Continue reading
Immune response and stage 4 melanoma
Stage 4 (Stage IV) melanoma is very difficult to treat. Even though stage I melanoma has an excellent prognosis; response rate for stage 4 melanoma with palliative biotherapies and chemotherapies is only approximately 10%. Clinicians and researchers are working hard to … Continue reading